ROME, March 4 (Reuters) - The European Commission has blocked the export of AstraZeneca (NASDAQ:AZN)'s coronavirus vaccine produced in Italy and destined for Australia after the drug manufacturer failed to meet its EU contract commitments, two sources said on Thursday.